Description

COMPOSITION: Each uncoated Sustained release tablet contains Vildagliptin 100 mg
FORMULATION: TABLETS
STATUS: PRESCRIPTION ONLY DRUG
DESCRIPTION: Debiglip tablet contains Vildagliptin, a new class of anti-diabetics that acts on the intestinal enzyme to control diabetes. It is prescribed in adjunct to diet control, exercise & other drugs to control type II diabetes.
SIDE EFFECTS: The main side effects are hypoglycemia (in combination with other drugs), tremor, dizziness, headache and Nausea.
DOSAGE/DIRECTIONS FOR USE: As Prescribed by Physician

Vildagliptin